Carbon 2010, 48:2335. 54. Lueking D, Gutierrez HR, Fonseca DA, Narayanan DL, Essendelft DV, Jain P, Cliord CEB: buy Caspase Inhibitor VI graphene to graphane: a theoretical study. J Amer Chem find more Soc 2006, 128:7758. 55. Ray NR, Srivastava AK, Grotzschel R: In search of graphane – a two-dimensional hydrocarbon. Cond Mat Mtrl Sci 2008, arXiv:0802–3998v1. 56. Elias DC, Nair RR, Mohiuddin TMG, Morozov SV, Blake P, Halsall MP, Ferrari AC, Boukhvalov DW, Katsnelson MI, Geim AK, Novoselov KS: Control of graphene’s properties by reversible hydrogenation: evidence for graphane. Sci 2009, 30323:610. 57. Savchenko A: Transforming graphene. Sci 2009, 323:589.

58. Tozzini V, Pellegrini V: Electronic structure and Peierls instability in graphene nanoribbons sculpted in graphane. Phys Rev B 2010, 81:113404. 59. Ao ZM, Hernández-Nieves AD, Peeters FM, Li S: Enhanced stability of hydrogen atoms at the graphene/graphane interface of nanoribbons. Appl Phys Lett 2010, AZD1080 mouse 97:256. 60. Flores MZS, Autreto PAS, Legoas SB, Galvao DS: Graphene to graphane: a theoretical study. Nanotechnol 2009, 20:465704. 61. Dora B, Ziegler K: Gaps and tails in graphene and graphane. New J Phys 2009, 11:095006. 62. Wang Y, Xu X, Lu J, Lin M, Bao Q, Ozyilmaz B, Loh KP: Toward high throughput interconvertible graphane-to-graphene growth and patterning. Nano 2010, 4:6146.

63. Sluiter MHF, Kawazoe : Cluster expansion method for adsorption: Application to hydrogen chemisorption on graphene. Phys Rev B 2003, 68:085410. 64. Sofo JO, Chaudhari AS, Barber GD: Graphane: a two-dimensional selleck chemical hydrocarbon. Phys Rev B 2007, 75:153401. 65. Wen XD, Hand L, Labet V, Yang T, Hoomann R, Ashcroft NW, Oganov AR, Lyakhov O: Benzene under high pressure: a story of molecular crystals transforming to saturated networks, with a possible intermediate metallic phase. Proc Natl Acad Sci 2011, 108:6833. 66. Leenaerts O, Peelaers H, Hernández-Nieves AD, Partoens B, Peeters FM: First-principles investigation of graphene fluoride and graphane. Phys Rev B 2010, 82:195436. 67. Bhattacharya A, Bhattacharya

S, Majumder C, Das GP: Third conformer of graphane: a first-principles density functional theory study. Phys Rev B 2011, 83:033404. 68. Samarakoon DK, Chen ZF, Nicolas C, Wang XQ: Structural and electronic properties of fluorographene. Small 2011, 7:965. 69. Samarakoon DK, Wang XQ: Chair and twist-boat membranes in hydrogenated graphene. ACS Nano 2009, 12:4017. 70. He C, Sun LZ, Zhang CX, Jiao N, Zhang KW, Zong J: Structure, stability and electronic properties of tricycle type graphane. Phys Status Solidi (RRL) -Rapid Research Letters 2012, 6:427. 71. Xue K, Xu Z: Strain effects on basal-plane hydrogenation of graphene: a first-principles study. Appled Phys Lett 2010, 96:063103. 72. Popova NA, Sheka EF: Mechanochemical reaction in graphane under uniaxial tension. Researchgate 2011, 06arXiv:01.

Therefore, the supercapacitive performance of graphene-ZnO 3-deazaneplanocin A hybrid based supercapacitor is significant improved. Conclusions In summary, the graphene-ZnO hybrid nanostructure as

an electrode material for solid-state supercapacitors was successfully synthesized using one-step hydrothermal BYL719 nmr method. The surface morphology, microstructure, composition, and capacitive behaviors of the as-prepared materials were well investigated. SEM and TEM images revealed the uniform distribution of ZnO nanorods on the Gr sheet substrate. In comparison with the specific capacitance of ZnO and pristine Gr electrode, the specific capacitance of graphene-ZnO hybrid electrode (156 F g−1 at a scan rate of 5 mV s−1) is significantly improved. Moreover, the material exhibited excellent electrochemical stability. The improved supercapacitance performance

of the graphene-ZnO hybrid was mainly attributed to the pseudocapacitance of the ZnO phase and the intrinsic double-layer capacitance of the Gr sheets. The low price, abundant resources, and environmental this website friendliness of ZnO may render their nanocomposites a promising candidate for practical applications. Acknowledgements The authors are grateful for support from the National Natural Science and Henan Province United Foundation of China (no. U1204601 and no. 51072063), Natural Science Foundation of Henan Province (no. 122300410298), Natural Science Foundation of Education Department

of Henan Province (no. 13A480365), and PhD Foundation of Zhengzhou University of Light Industry (no. 2010 BSJJ 029). References 1. Yuan LY, Xiao X, Ding TP, Zhong JW, Zhang XH, Shen Y, Hu B, Huang YH, Zhou J, Wang ZL: Paper-based supercapacitors for self-powered nanosystems. Angew Chem Int Ed 2012, 51:4934–4938.CrossRef 2. Li ZJ, Zhou YJ, Zhang YF: Semiconducting single-walled carbon Janus kinase (JAK) nanotubes synthesized by S-doping. Nano-Micro Lett 2009, 1:9–13. 3. Zhai T, Wang FX, Yu MH, Xie SL, Liang CL, Li C, Xiao FM, Tang RH, Wu QX, Lu XH, Tong YX: 3D MnO2–graphene composites with large areal capacitance for high-performance asymmetric supercapacitors. Nanoscale 2013, 5:6790–6796.CrossRef 4. Wu J, Wang ZM, Dorogan VG, Li SB, Zhou ZH, Li HD, Lee JH, Kim ES, Mazur YI, Salamo GJ: Experimental analysis of the quasi-Fermi level split in quantum dot intermediate-band solar cells. Appl Phys Lett 2012, 101:043904.CrossRef 5. Chang TQ, Li ZJ, Yun GQ, Jia Y, Yang HJ: Enhanced photocatalytic activity of ZnO/CuO nanocomposites synthesized by hydrothermal method. Nano-Micro Lett 2013,5(3):163–168.CrossRef 6. Yuan LY, Lu XH, Xiao X, Zhai T, Dai JJ, Zhang FC, Hu B, Wang X, Gong L, Chen J, Hu CG, Tong YX, Zhou J, Wang ZL: Supercapacitors based on carbon nanoparticles/MnO2. nanorods hybrid structure. ACS Nano 2012, 6:656–661.CrossRef 7.

Small increases in sea expression were found in the transitional phase at pH 7.0 and

6.5. However, relative sea expression in the transitional phase at pH 6.0 (n = 2) and 5.5 (n = 3) were high, nine and four times higher, respectively, than in the exponential growth phase. At pH 5.5, extended sea mRNA expression was observed with the peak associated with the transitional phase. However, sea mRNA was not possible to detect Epoxomicin in vivo at pH 5.0 or 4.5. Figure 1 Growth and relative sea levels of S. aureus Mu50 when grown at different pH levels. (A) Growth curves determined by OD measurements at 620 nm at pH 7.0, 6.5, 6.0, 5.5, 5.0, and 4.5. (B) Relative expression (RE) of sea at pH 7.0, 6.5, 6.0, and 5.5. Solid and dashed lines represent growth and RE, respectively. For pH 6.0 and 5.5, the mean and standard deviations of independent batch cultures; two and three, respectively, is displayed. selleck kinase inhibitor extracellular SEA was detected in all cultivations of S. aureus Mu50 and the levels increased over time at tested

pH levels allowing growth (Figure 2). The SEA levels increased from pH 7.0 to 6.0 and decreased significantly at lower pH levels, i.e. pH 5.5, 5.0 and 4.5. The specific extracellular SEA concentrations (i.e. the extracellular SEA concentrations divided by the value of the OD at that point in time) correlating the SEA production to growth, showed the same trend. The specific SEA concentrations were 100, 450, 510, 210, 40, and 870 ng per ml and OD unit for pH 7.0, 6.5, 6.0, 5.5, 5.0, and 4.5, respectively. The specific SEA concentration at pH 4.5 is misleading since the culture was not growing. Figure 2 SEA levels, growth rate and sea this website expression of S. aureus Mu50 at different pH levels. Extracellular RVX-208 SEA levels in the mid-exponential, the transitional, the early stationary, and late stationary growth phase;

maximal growth rate (μmax), and relative sea levels (RE) in the transitional phase. At pH 4.5 the SEA values are after 10, 24 and 30 h of growth, shown in the figure as transitional, early stationary and late stationary phase samples, respectively. The values at pH 6.0 and 5.5 are the average and standard deviations of two and three independent batch cultures, respectively. Phage-associated sea expression Samples of bacterial cells and culture supernatants from S. aureus Mu50 were collected to determine the trends of the relative sea gene copy number (and thus the replicative form of the sea-carrying phage) and relative phage copy number in the four growth phases at different pH values (Figure 3). The relative sea gene copy number was low throughout the cultivations at pH 7.0 and 6.5. The sea gene copy number peaked at pH 5.5, being twelve times higher than at pH 7.0 in the mid-exponential growth phase, and a trend of the sea gene copy number decreasing over time was observed at this pH. The sea gene copy number increased over time at pH 5.0 and 4.

Acknowledgements The authors would like to thank to the Faculty of Sciences from Universidad de los Andes, the Evaluation-orientation de la Coopération Scientifique (ECOS project No. C11A02) and the National Science Foundation/BREAD selleck chemicals (Basic Research to

Enable Agricultural Development) grant (Award 0965418) for funding this study. We also thank the International Center for Tropical Agriculture (CIAT) for enabling the sampling at their experimental cassava field located in Corpoica (La Libertad, Meta). We also thank Daniela Osorio for help in the edition of manuscript style. Finally we thank Estefanía Luengas for help in figure editing. Electronic supplementary material Additional file 1: Primers used for the AFLP amplification and VNTR amplification and sequencing. (PDF 38 KB) References 1. Lannou C, Hubert P, Gimeno C: Competition and interactions among stripe rust pathotypes in wheat-cultivar mixtures. Plant Pathol 2005,54(5):699–712.CrossRef 2. Mundt CC: Use of multiline cultivars and cultivar mixtures for disease management. Annu Rev Phytopathol 2002, 40:381–410.PubMedCrossRef 3. McDonald BA, Linde C: Pathogen population genetics, evolutionary potential, and durable resistance. Annu Rev Phytopathol 2002, 40:349–379.PubMedCrossRef AZD1480 4. Stukenbrock

EH, McDonald BA: The origins of plant pathogens in agro-ecosystems. Annu Rev Phytopathol 2008, 46:75–100.PubMedCrossRef 5. Barrett LG, Thrall PH, Burdon JJ, Linde CC: Life history determines genetic structure and evolutionary Florfenicol potential of host-parasite interactions. Trends Ecol Evol 2008,23(12):678–685.PubMedCentralPubMedCrossRef 6. Maraite H: Xanthomonas campestris pathovars on cassava: cause of bacterial blight and bacterial necrosis. In Xanthomonas. Edited by: Swings JG, Civerolo EL. London: Chapman and Hall; 1993:18–24. 7. Lozano J: Cassava bacterial blight: a manageable disease. Plant Dis 1986, 70:1089–1093.CrossRef

8. Restrepo S, Velez CM, Duque MC, Verdier V: Genetic structure and population dynamics of Xanthomonas axonopodis pv. manihotis in Colombia from 1995 to 1999. Appl Environ Microb 2004,70(1):255–261.CrossRef 9. Restrepo S, Velez CM, Verdier V: Measuring the genetic diversity of Xanthomonas axonopodis pv. manihotis within different fields in Colombia. Phytopathology 2000,90(7):683–690.PubMedCrossRef 10. Ogunjobi AA, Fagade OE, Dixon AG: Comparative analysis of genetic variation among Xanthomonas axonopodis pv manihotis isolated from the western states of Nigeria using RAPD and AFLP. Indian J Microbiol 2010,50(2):132–138.PubMedCentralPubMedCrossRef 11. Verdier V, Boher B, Maraite H, Geiger JP: Pathological and molecular FXR agonist inhibitor characterization of Xanthomonas campestris isolates causing diseases of cassava (Manihot esculenta). Appl Environ Microb 1994, 60:4478–4486. 12. Verdier V, Dongo P, Boher B: Assessment of genetic diversity among strains of Xanthomonas campestris pv manihotis. J Gen Microbiol 1993, 139:2591–2601.CrossRef 13.

Washington D. C: American Academy of Microbiology; 2008:1–41. [AMERICAN ACADEMY OF MICROBIOLOGY] http://​www.​asm.​org 2. Harris NB, Barletta RG:

Mycobacterium avium subsp. Paratuberculosis in veterinary medicine. Clin Microbiol Rev 2001,14(3):489–512.click here PubMedCrossRef 3. Schönenbrücher H, Abdulmawjood A, Failing K, Bülte M: New triplex real-time PCR assay for detection of Mycobacterium avium subsp. paratuberculosis in bovine feces. Appl Environ Microbiol 2008,74(9):2751–2758.PubMedCrossRef Cytoskeletal Signaling inhibitor 4. Slana I, Kralik P, Kralova A, Pavlik I: On-farm spread of mycobacterium avium subsp. Paratuberculosis in raw milk studied by IS900 and F57 competitive real time quantitative PCR and culture examination. Int J Food Microbiol 2008,128(2):250–257.PubMedCrossRef 5. Richter E, Wessling J, Lugering N, Domschke W, Rusch-Gerdes S: Mycobacterium avium subsp. paratuberculosis infection in a patient with HIV, Germany. Emerg Infect Dis 2002,8(7):729–731.PubMedCrossRef 6. Radomski N, Thibault VC, Karoui C, de Cruz K, Cochard T, Gutierrez C, Supply P, Biet F, Boschiroli ML: Determination of genotypic diversity of mycobacterium avium

subspecies from human and animal origins by mycobacterial interspersed repetitive-unit-variable-number tandem- repeat and IS1311 restriction fragment length polymorphism typing methods. J Clin Microbiol 2010,48(4):1026–1034.PubMedCrossRef 7. Hermon-Taylor J: Mycobacterium avium subspecies paratuberculosis, crohn’s disease and the doomsday scenario. Gut Pathog LOXO-101 nmr 2009,1(1):15.PubMedCrossRef 8. Pierce ES: Ulcerative colitis and crohn’s disease: is mycobacterium avium Decitabine order subspecies paratuberculosis the common villain? Gut Pathog 2010,2(1):21.PubMedCrossRef 9. Lidar

M, Langevitz P, Shoenfeld Y: The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 2009,11(9):558–563.PubMed 10. Sartor RB: Does Mycobacterium avium subspecies paratuberculosis cause crohn’s disease? Gut 2005,54(7):896–898.PubMedCrossRef 11. Woo SR, Czuprynski CJ: Tactics of Mycobacterium avium subsp. paratuberculosis for intracellular survival in mononuclear phagocytes. J Vet Sci 2008,9(1):1–8.PubMedCrossRef 12. Abubakar I, Myhill D, Aliyu SH, Hunter PR: Detection of Mycobacterium avium subspecies paratuberculosis from patients with crohn’s disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis 2008,14(3):401–410.PubMedCrossRef 13. Macfarlane GT, Cummings JH: Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ 1999,318(7189):999–1003.PubMedCrossRef 14. Furrie E, Senok AC, Frank DN, Sullivan KE: Pondering probiotics. Clin Immunol 2006,121(1):19–22.PubMedCrossRef 15. Heller KJ: Probiotic bacteria in fermented foods: product characteristics and starter organisms. Am J Clin Nutr 2001,73(2 Suppl):374S-379S.PubMed 16.

As

carbon number increases the Critical Vesicle Concentration (CVC), defined as the minimal concentration of amphiphiles that allows vesicle formation, decreases. Decanoic acid (DA) is useful as a model system for prebiotic membranes because its CVC is 30 mM at room temperature. A recent study showed that a mix of C6-C9 fatty acids added to decanoic acid lowers the CVC significantly (Cape et al. 2011). Pure fatty acid vesicles are relatively permeable to ionic and polar solutes. For instance, decanoic acid vesicles cannot capture dyes or tRNA (Maurer et al. 2009), which means these membranes would need to incorporate stabilizing compounds if they were to serve as containers for important molecules such as RNA in primitive forms of cellular life. A few prebiotically plausible

stabilizers have been discovered that lower the CVC, reduce membrane permeability and provide stabilization over alkaline JQEZ5 in vitro pH ranges. These include fatty alcohols and monoacyl glycerol derivatives (Monnard and Deamer 2003; Maurer et al. 2009) or mixed cationic and anionic amphiphiles (Namani and Deamer 2008). Another source of potential membrane stabilizing compounds are polycyclic aromatic hydrocarbons (PAHs) which are abundant in the ISM (Gredel et al. 2010) galactic and extragalactic regions, protoplanetary disks and solar system objects (Tielens 2008; Peeters et al. 2011). These accumulate into planetesimals

from which solar system bodies, such as planets, comets and asteroids form. Carbonaceous Tozasertib purchase meteorites are fragments of asteroids and comets and contain ~3 % organic matter. Polycyclic aromatic hydrocarbons such as pyrene Florfenicol and fluoranthene, oxidized aromatic species ( 9-fluorenone, 9-anthrone, 9,10-anthraquinone, and phenanthrenedione) have been identified in the soluble phase and substantial find more amounts of kerogen-type material composed largely of polymerized aromatics are present in the insoluble phase (Ashbourn et al. 2007). The Aromatic World hypothesis (Ehrenfreund et al. 2006) postulates that aromatic material, being more resistant to degradation by radiation and higher temperatures, may have had functional and structural roles in the emerging of early life forms. Although macromolecular carbon consisting of aromatic units is often perceived as inert, decomposition of these networks by hydropyrolysis can release smaller PAH molecules (Mautner et al. 1995). Oxidized PAHs would then be available for further reactions, thereby adding more diversity to the carbon inventory (Cody and Alexande 2005). PAHs have the potential to fulfill a variety of functions in prebiotic container chemistry. For instance, amphiphilic PAHs could increase resistance of vesicles to divalent cations, which at relatively low concentrations cause collapse of fatty acid vesicles (Monnard et al. 2002).

When we monitored infection of P. aeruginosa PAO1 in ASM we noticed a 50-fold lower concentration of phage particles. This indicates a reduced efficiency of phage infection by JG024 under simulated chronic infection using the artificial TPX-0005 ic50 sputum medium. In parallel we tested a P. aeruginosa CF-isolate, strain BT73, for susceptibility to phage infection in LB and ASM. Unexpectedly, we noticed only a 1.9-fold lower phage number in ASM compared to LB (Figure 4). We noticed that phage JG024 was less effective against the CF isolate under both conditions, since approximately tenfold less phage particles were produced under both conditions compared to PAO1. However, while strain BT73 is less susceptible to INK1197 clinical trial phage lysis, the

efficiency does not decrease dramatically under ASM growth conditions. Figure 4 Infection assay of JG024 in ASM medium. Phage growth during infection assay in LB medium (dark grey bars) and ASM medium (light grey bars). Changes in phage concentration are described as n-fold. In contrast to the P. aeruginosa PAO1 strain the CF-isolate BT73 is mucoid and secretes

the exopolysaccharide alginate. We wondered if alginate overproduction could explain the observed results. It was recently published that even non-mucoid strains like the wild type PAO1 express the exopolysaccharide alginate in response to oxygen-limiting conditions [33]. We also observed that cultures of PAO1 in ASM, which mimics the CF lung, were highly viscous compared to the cultures in LB medium, suggesting a high production of alginate by the wild type PAO1 in this medium. If alginate is the factor in our experimental setup which decreases phage infection efficiency,

learn more a mucoid Bleomycin cell line variant of strain PAO1 should show a similar result as the clinical isolate BT73. Therefore, we repeated the phage infection experiments in LB and ASM with a P. aeruginosa mucA mutant strain. We observed again only a 1.6-fold decrease in ASM and an overall approximately tenfold reduction in phage particles when compared with P. aeruginosa PAO1 (Figure 4). These results are in agreement with our hypothesis that alginate overproduction reduces phage infection efficiency. Moreover, they point to alginate as the dominant factor for the decrease in phage infection efficiency in ASM. To verify this result, we performed the same experiment with P. aeruginosa PAO1 in LB medium and increasing alginate concentrations. We chose alginate concentrations of 50, 100, 200, 500 μg/ml up to 1000 μg/ml, since non-mucoid P. aeruginosa strains have been reported to produce 50-200 μg/ml alginate, while mucoid isolates produce up to 1000 μg/ml alginate [34–36]. In accordance with our hypothesis, the presence of alginate reduced phage multiplication in our test assay. A concentration of 50 to 200 μg/ml alginate resulted in an almost 20-fold reduction of phage particles compared to LB medium alone in accordance with the 50-fold reduction of phage particles observed in ASM compared to LB.

faecium 212 (PE; 1 × 109 + 1 × 109 CFU/d) on steers fed a 90% steam-rolled barley based diet. The probiotics did not affect ruminal pH, but P15 supplementation increased butyrate proportion and protozoa population with a concomitant reduction in amylolytic bacteria and S. bovis counts Selleckchem NU7026 [47]. In the other study, P. freudenreichii PF24 in association with Lb. acidophilus 747 (1 × 109 + 2 × 109 CFU/d) or Lb. acidophilus 747 and Lb. acidophilus 45 (1 × 109 + 2 × 109 + 5 × 108 CFU/d) given to mid-lactation Holstein dairy cows fed a 41% concentrate based diet did not affect the ruminal fermentations or pH, which was approximately 6.15 for control and probiotic-supplemented

cows [48]. According to our present hypothesis that probiotics become effective when the ruminal ecosystem is unstable, it appears that the conditions were not acidotic enough in the study of Raeth-Knight et al. [48], whereas the effects reported by Ghorbani et al. [47] may indicate a decrease in acidosis risk even though the ruminal

pH was not affected by probiotic supplementation [47]. In other studies reporting the use of probiotic bacteria, beneficial effects on ruminal pH were only observed for treatments associating bacteria and yeast [11, 12], and never for bacteria alone [29, 47–50]. Thus the beneficial effects on pH reported by Nocek et al. [11] and Chiquette [12] were probably not specific to the bacteria used, and may be attributed to S. cerevisiae, which has been

shown to stabilize ruminal pH [8, 9, 51]. However, a synergistic effect cannot be excluded as, to our knowledge, there have been no studies VX-661 mw comparing yeast and bacteria oxyclozanide used alone and in association. The present work is the first to report a specific positive effect of bacterial probiotics on ruminal pH during SARA. The mode of action of these probiotics, consisting of Lactobacillus and Propionibacterium selected strains, could not be clearly associated with quantitative characteristics of the rumen microbial ecosystem such as bacterial and protozoal populations. Conclusion This study shows for the first time that Lactobacillus and Propionibacterium probiotic strains may be effective in stabilizing ruminal pH and therefore preventing SARA risk, but they were not effective against IWP-2 clinical trial lactic acidosis. The present results also suggest that the effectiveness of probiotics is compromised by ruminal fermentations, and are effective when the ruminal ecosystem is unstable. Although their mode of action needs to be further elucidated, we hypothesize that the effect of the probiotic strains used on ruminal pH was achieved by modulating the rumen microbiota, which was more diverse, by improving cellulolytic activity and by limiting the proliferation of lactic acid-producing bacteria. The combination of lactobacilli and Propionibacterium P63 seems to be more efficient in preventing SARA than P63 alone, possibly due to a synergistic effect between the strains.

Francisco 7 6 3 8 18 10 M830 1993 Vactosertib nmr French Guiana Institut Pasteur Modesto 10 6 4 6 19 13   Consensus         9 6 4 7 x x III RC9† 1985 Kenya

    9 6 3 7 26 20 M650 1976 India National Institute of Cholera 762/76 8 7 4 8 29 28 M647 1970 Bangladesh CCUG 13119 9 7 4 7 14 28 M795 1976 Bangladesh PF-02341066 mw University of Maryland 30167 9 7 4 7 18 32 M797 1986 Hong Kong University of Hong Kong V31 9 7 4 7 22 36 N16961† 1971 Bangladesh     9 7 4 7 23 14   Consensus         9 7 4 7 x x IV M646 1979 Bangladesh CCUG 9193 9 7 4 7 20 21 M822 1983 Vietnam Institut Pasteur 359 10 7 7 8 17 19 M764 1989 Thailand AFRIMS FX-41-3 7 7 4 5 15 24 M740 1985 Thailand AFRIMS D-145 9 7 4 5 15 25 M723 1982 Thailand AFRIMS WR-32 9 7 4 5 20 22 M714 1979 Thailand AFRIMS 96A/CO 11 8 4 8 20 19 M652 1981 India National Institute of Cholera 1200/81 9 7 4 8 20 13   Consensus         9 7 4 x 20 x V M824

1987 Algeria Institut Pasteur Mekki 8 7 4 8 28 14 M827 1990 Guinea Institut Pasteur Guinea1 8 7 4 8 24 16 M828 1991 Morrocco Institut Pasteur Akretche 8 7 4 8 23 17 M791 1991 Thailand AFRIMS CX-043-0 8 7 4 8 12 20 MJ1236† 1994 Bangladesh     8 7 4 8 12 19 CIRS-101† 2002 Bangladesh     9 3 3 9 16 11 B33† 2004 Mozambique     8 7 4 8 11 20 M654 1991 India National Institute of Cholera 413/91 7 7 4 8 15 20   Consensus         8 7 4 8 x x VI M834 1993 Bangladesh ICDDR A25365 10 7 3 8 22 11 M833 1993 Bangladesh ICDDR A24698 9 7 3 9 23 11 M985, M984, SYN-117 cell line M988, M831 1992/ 1993 India/ Bangladesh ICDDR F642/F641/ F657/ A26094 10 7 3 9 23 11 M987 1992 India ICDDR F638 10 7 3 9 23 12 M989 1993 India ICDDR 2412-93 10 7 3 9 22 13 M986 1992 India ICDDR F643 12 7 3 9 23 11 M835 Rebamipide 1993 Bangladesh ICDDR A25080 10 7 3 9 24 12 M537, M542# 1993 India/ Bangladesh ICDDR SK556/ F653 10 7 3(4) 9 23 13 M545 1993 India ICDDR MO229 10 7 3 9 21 13 MO10† 1992 India     10 7 3 9 22 12   Consensus#         10 7 3 9 23 x *MLVA profile is made up of the repeat numbers (also as allele designations) for the following VNTR loci (in order): vc0147, vc0437, vc1457, vc1650, vca0171

and vca0283. $Pre-7th: pre-seventh pandemic isolates. All other isolates are 7th pandemic (I-V) or its derivative O139 (V) isolates. The roman numerals (I-VI) denote SNP groups as described in Lam et al. [12]. †Data for these strains were from published genome sequences. Note that no VNTR data for the recently sequenced Haitian isolates and Peru isolate C6706. The level of variation differed across the six VNTRs analysed. In total, 7, 6, 3, 5, 19 and 24 alleles were observed for vc0147, vc0437, vc1457, vc1650, vca0171 and vca0283 respectively.

Eur J Med Chem 44:1223–1229CrossRefPubMed Bojarski AJ

(2006) Pharmacophore models for metabotropic 5-HT receptor ligands. Curr Top Med Chem 6:2005–2026CrossRefPubMed Bronowska A, Leś A, Chilmonczyk Z, check details Filipek S, Edvardsen O, Ostensen R, Sylte I (2001) Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors. Bioorg Med Chem 9:881–895CrossRefPubMed Chilmonczyk Z, Szelejewska-Wozniakowska A, Cybulski J, Cybulski M, Koziol AE, Gdaniec M (1997) Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore. Arch Pharm (Weinheim) 330:146–160CrossRef Czopek A, Byrtus H, Kołaczkowski M, Pawłowski M, Dybała M, Nowak G, Tatarczyńska E, Wesołowska A, Chojnacka-Wójcik E (2010) Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives.

Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic Selleck PCI-34051 activity. Eur J Med Chem 45:1295–1303CrossRefPubMed Filosa R, Peduto A, de Sapanisertib cost Caprariis P, Saturnino C, Festa M, Petrella A, Pau A, Pinna GA, La Colla P, Busonera B, Loddo R (2007) Synthesis and antiproliferative properties of N3/8-disubstituted 3,8-diazabicyclo[3.2.1]octane analogues of 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl-piperazine. Eur J Med Chem 42:293–306CrossRefPubMed González-Gómez JC, Santana L, Uriarte E, Brea J, Villazón M, Loza MI, De Luca M, Rivas ME, Montenegro GY, Fontenla JA (2003) New arylpiperazine derivatives with high affinity

for alpha1A, D2 and 5-HT2A receptors. Bioorg Med Chem Lett 13:175–178CrossRefPubMed Fossariinae Hackling A, Ghosh R, Perachon S, Mann A, Höltje HD, Wermuth CG, Schwartz JC, Sippl W, Sokoloff P, Stark H (2003) N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands. J Med Chem 46:3883–3899CrossRefPubMed Kerns EH, Di L (2008) Drug-like properties: concepts structure design and methods: from ADME to toxicity optimization. Academic Press, Amsterdam Kim MK, Lee HS, Kim S, Cho SY, Roth BL, Chong Y, Choo H (2012) 4-Aminoethylpiperazinyl aryl ketones with 5-HT1A/5-HT7 selectivity. Bioorg Med Chem 20:1139–1148CrossRefPubMed Klabunde T, Evers A (2005) GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects. ChemBioChem 6:876–889CrossRefPubMed Leopoldo M (2004) Serotonin(7) receptors (5-HT(7)Rs) and their ligands. Curr Med Chem 11:629–661CrossRefPubMed Lepailleur A, Bureau R, Paillet-Loilier M, Fabis F, Saettel N, Lemaître S, Dauphin F, Lesnard A, Lancelot JC, Rault S (2005) Molecular modeling studies focused on 5-HT7 versus 5-HT1A selectivity. Discovery of novel phenylpyrrole derivatives with high affinity for 5-HT7 receptors.